6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus – the met-remodel trial

MLA

Shaween Al-Talabany, et al. “6 Metformin Regresses Left Ventricular Hypertrophy in Normotensive Patients with Coronary Artery Disease without Type 2 Diabetes Mellitus – the Met-Remodel Trial.” Acute Coronary Syndromes, June 2018. EBSCOhost, https://doi.org/10.1136/heartjnl-2018-bcs.6.

APA

Shaween Al-Talabany, U Bhalraam, Muhammed Hussain, Chim C. Lang, Jagdeep Singh, Graheme Houston, Stephen J. Gandy, Anna Maria Choy, Ify R. Mordi, Fatima Baig, Angela McKinnie, Mohapradeep Mohan, Jacob George, Faisel Khan, & Allan D. Struthers. (2018). 6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus – the met-remodel trial. Acute Coronary Syndromes. https://doi.org/10.1136/heartjnl-2018-bcs.6

Chicago

Shaween Al-Talabany, U Bhalraam, Muhammed Hussain, Chim C. Lang, Jagdeep Singh, Graheme Houston, Stephen J. Gandy, et al. 2018. “6 Metformin Regresses Left Ventricular Hypertrophy in Normotensive Patients with Coronary Artery Disease without Type 2 Diabetes Mellitus – the Met-Remodel Trial.” Acute Coronary Syndromes, June. doi:10.1136/heartjnl-2018-bcs.6.